01 April 2004
Bradykinin-induced alterations of insulin-receptor interaction in rat adipose tissue under normo- and hypothermic conditions
Magdalena Gibas, Teresa Torlińska, Edyta Mądry, Paweł MaćkowiakMed Sci Monit 2004; 10(4): BR109-114 :: ID: 11627
Abstract
Background:In this study we compared the effect of bradykinin (BK) on insulin-receptor interaction in rat adipose plasma membranes under normothermic and hypothermic conditions.
Material/Methods: Plasma membranes were prepared and purified according to Havrankova and binding assay was performed using ([sup]125[/sup]I) – insulin. The kinetic parameters of the hormone-receptor interaction were analyzed according to Scatchard using the LIGAND – Pc v.3.1 computer program. Additionally, we determined blood glucose and insulin concentrations. The results were interpreted statistically according to one-way analysis of variance (ANOVA).Results: Statistically significant changes mainly involved the low-affinity receptor class. In normothermic rats, BK provoked a decrease in insulin-receptor affinity (expressed as a drop in the association constant Ka2 by 64% and enhancement in the dissociation constant Kd2 by 215%), which was compensated by a 188% increase in the number of insulin receptors. Therefore, association constant times binding capacity remained unchanged. Administration of BK resulted in a decrease in serum glucose concentration by about 50%, while the insulin level did not change. Hypothermia lowered insulin concentration by 68% and elevated both the value of the association constant times binding capacity by 166% and the insulin-receptor affinity (Kd2 decreased by 71% and Ka2 increased markedly by about 771%). Administration of BK to hypothermic rats elevated blood insulin level by 180% and diminished (by about 64%) the value of association constant times binding capacity.Conclusions: The results indicate that bradykinin plays a significant role in carbohydrate metabolism and may influence insulin-receptor interaction under both normothermic and hypothermic conditions.
Keywords: Adipose Tissue - drug effects, Adipose Tissue - metabolism, Bradykinin - pharmacology, Cell Membrane - drug effects, Cell Membrane - metabolism, Hypothermia, Induced, Insulin - metabolism, Receptor, Insulin - metabolism, Adipose Tissue - metabolism, Bradykinin - pharmacology, Cell Membrane - metabolism, Hypothermia, Induced, Insulin - metabolism, Receptor, Insulin - metabolism
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Comparative Analysis of Laser Therapies for Striae Distensae: Fractional CO₂ vs Combined Q-Switch Nd:YAGMed Sci Monit In Press; DOI: 10.12659/MSM.947464
Database Analysis
Utility of Central Venous Oxygen Saturation Gradient in Predicting Mortality in Dialysis with Catheter AccessMed Sci Monit In Press; DOI: 10.12659/MSM.947298
Clinical Research
Intraoperative Renal Near-Infrared Spectroscopy Monitoring as a Predictor of Renal Outcomes in Cardiac SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947462
Clinical Research
Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical CancerMed Sci Monit In Press; DOI: 10.12659/MSM.945964
Most Viewed Current Articles
17 Jan 2024 : Review article 7,110,480
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,343
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,671
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 21,887
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912